This review will focus on the development of vaccines against influenza A/H5N1 strains. Reducing the impact of the potential pandemic would entail pharmaceutical and nonpharmaceutical interventions.

Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 becomes an increasing concern.

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

Robert F. Kennedy Jr. has already tarnished his legacy as Health and Human Services secretary with numerous false statements and questionable decisions about vaccines.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

While H5N1 does not have high mortality rates in dairy cows, the infection causes decreases milk production and milk quality, ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I am not going to go into HHS and impose my preordained opinions on anybody ...

From the outset of the Trump administration, bird flu, or H5N1 avian influenza, has flown rather conspicuously — and in fact ...

According to the CDC, there has been a decline in animal infections and no reports of human cases since February.

Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Cambodia’s health ministry today reported a seventh human H5N1 avian flu case for the month of June, a 36-year-old woman from the same province as the last three cases, part of an ongoing rise in ...